Financhill
Back

Biogen Quote, Financials, Valuation and Earnings

Biogen Price Quote

$146.57
+0.10 (+-0.56%)
(Updated: December 21, 2024 at 5:17 AM ET)

Biogen Key Stats

Sell
36
Biogen (BIIB) is a Sell

Day range:
$145.07 - $147.85
52-week range:
$145.07 - $268.30
Dividend yield:
0%
P/E ratio:
18.38
P/S ratio:
2.23
P/B ratio:
1.3%

Volume:
5.8M
Avg. volume:
1.7M
1-year change:
-40.98%
Market cap:
$21.3B
Revenue:
$9.8B
EPS:
$11.07

How Much Does Biogen Make?

Data Unavailable

Is Biogen Growing As A Company?

Data Unavailable

Biogen Stock Price Performance

  • Did Biogen Stock Go Up Last Month?
    Biogen share price went down by -6.11% last month
  • Did BIIB's Share Price Rise Over The Last Year?
    BIIB share price fell by -40.98% over the past 1 year

What Is Biogen 52-Week High & Low?

  • What Is Biogen’s 52-Week High Share Price?
    Biogen has traded as high as $268.30 over the past 52 weeks
  • What Is Biogen’s 52-Week Low Share Price?
    Biogen has traded as low as $145.07 over the past 52 weeks

Biogen Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Biogen?

Data Unavailable

Is Biogen Cash Flow Positive?

Data Unavailable

Biogen Return On Invested Capital

Data Unavailable

Biogen Earnings Date & Stock Price

  • What Is Biogen's Stock Price Today?
    A single share of BIIB can be purchased today for 146.47
  • What Is Biogen’s Stock Symbol?
    Biogen trades on the S&P500 under the ticker symbol: BIIB
  • When Is Biogen’s Next Earnings Date?
    The next quarterly earnings date for Biogen is scheduled on February 13, 2025
  • When Is BIIB's next ex-dividend date?
    Biogen's next ex-dividend date is June 18, 2020
  • How To Buy Biogen Stock?
    You can buy Biogen shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Biogen Competitors

  • Who Are Biogen's Competitors?
    Below is a list of companies who compete with Biogen or are related in some way:
    • Eli Lilly and Co (LLY)
    • Moderna Inc (MRNA)
    • Pfizer Inc (PFE)
    • Regeneron Pharmaceuticals Inc (REGN)
    • Sage Therapeutics Inc (SAGE)

Biogen Dividend Yield

Data Unavailable

Biogen Analyst Estimates

YoY Growth Past Surprise
EPS: -1.72% 7.79%
Revenue: -2.55% 1.28%

Analyst Recommendations

Buy Recommendations: 13
Hold Recommendations: 15
Sell Recommendations: 0
Price Target: 242.83
Upside from Last Price: 65.79%

Major Shareholders

Data Unavailable